ACOR Financial Facts
Interest income: 46KProvision for income taxes: -3.02M
See Full Income Statement
Other assets: 5.81M
Accounts payable: 18.56M
See Full Balance Sheet
Acorda Therapeutics, Inc. (ACOR) Earnings
|
Expand Research on ACOR
Next EPS Date | N/A | EPS Growth Rate | -139.7% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | -188.2% | Revenue Growth Rate | +63.1% *Last Qtr. |
Average % Move 1-Wk after EPS | -8.4% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
8/8/23 | Q223 | -$7.55 | N/A | N/A | $29.68M | N/A | N/A | Details | |||
8/4/22 | Q222 | -$3.15 | -$0.36 | -$2.79 | $18.2M | $29.1M | N/A | Details | |||
3/4/21 | Q420 | -$2.50 | -$1.48 | -$1.02 | $38.16M | $34M | N/A | Details | |||
5/11/23 | Q123 | -$0.69 | N/A | N/A | $22.25M | N/A | N/A | Details | |||
2/15/18 | Q417 | $0.61 | $1.05 | -$0.44 | $188.4M | $174.75M | = | Details | |||
5/2/18 | Q118 | $0.14 | $0.47 | -$0.33 | $106.2M | $129.87M | = | Details | |||
11/4/11 | Q311 | $0.40 | $0.73 | -$0.33 | $93.03M | $90.78M | N/A | Details | |||
10/31/17 | Q317 | $0.43 | $0.65 | -$0.22 | $141.07M | $150.64M | = | Details |